The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis

Commons RJ., Simpson JA., Thriemer K., Humphreys GS., Abreha T., Alemu SG., Añez A., Anstey NM., Awab GR., Baird JK., Barber BE., Borghini-Fuhrer I., Chu CS., D'Alessandro U., Dahal P., Daher A., de Vries PJ., Erhart A., Gomes MSM., Gonzalez-Ceron L., Grigg MJ., Heidari A., Hwang J., Kager PA., Ketema T., Khan WA., Lacerda MVG., Leslie T., Ley B., Lidia K., Monteiro WM., Nosten F., Pereira DB., Phan GT., Phyo AP., Rowland M., Saravu K., Sibley CH., Siqueira AM., Stepniewska K., Sutanto I., Taylor WRJ., Thwaites G., Tran BQ., Tran HT., Valecha N., Vieira JLF., Wangchuk S., William T., Woodrow CJ., Zuluaga-Idarraga L., Guerin PJ., White NJ., Price RN.

DOI

10.1016/s1473-3099(18)30348-7

Type

Journal article

Journal

The Lancet Infectious Diseases

Publisher

Elsevier BV

Publication Date

09/2018

Volume

18

Pages

1025 - 1034

Permalink Original publication